Member Exclusive Regulatory News

US FDA approves bioprinted solution for pediatric microtia

3DBio Therapeutics (NY, USA) has announced US FDA rare pediatric disease designation for ear reconstruction in microtia patients.

Go to the profile of Georgi Makin
Dec 11, 2019

Please sign in or register for FREE

No comments yet.